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Background: The clinical presentation of panic disorder and panic attack overlaps many symptoms typically
experienced in coronary heart disease (CHD). Etiological links between panic disorder and CHD are controversial
and remain largely tenuous. This systematic review aims to pool together data regarding panic disorder with
respect to incident CHD or myocardial infarction.
Methods/Design: Electronic databases (MEDLINE, EMBASE, PsycINFO and SCOPUS) will be searched using a search
strategy exploding the topics for CHD and panic disorder. Authors and reference lists of included studies will also
be contacted to identify additional published and unpublished studies. Eligibility criteria are as follows: Population:
persons without CHD who meet criteria for panic disorder, panic attack, anxiety neurosis or elevated panic disorder
symptoms; Comparison: persons without CHD who do not meet criteria for panic disorder, panic attack, anxiety
neurosis or elevated panic disorder symptoms; Outcome: verified fatal and non-fatal CHD at follow-up; including
coronary revascularization procedure, coronary artery disease, and myocardial infarction. Studies adopting self-report
CHD will be ineligible. Screening will be undertaken by two independent reviewers with disagreements resolved
through discussion. Data extraction will include original data specified as hazard ratios, risk ratios, and original cell
data if available. Risk of bias assessment will be undertaken by two independent reviewers. Meta-analytic methods
will be used to synthesize the data collected relating to the CHD outcomes with Cochrane Review Manager 5.3.
Discussion: This systematic review aims to clarify whether panic disorder is associated with elevated risk for
subsequent CHD. An evaluation of the etiological links between panic disorder with incident CHD might inform
evidence-based clinical practice and policy concerning triaging chest pain patients, diagnostic assessment, and
psychiatric intervention with panic disorder patients.
Systematic review registration: PROSPERO CRD42014014891.
Keywords: Panic disorder, Panic attack, Anxiety disorder, Anxiety neurosis, Coronary heart disease, Myocardial
infarction, Systematic review, Meta-analysis, Protocol, EtiologyBackground
Panic disorder is among the most prevalent mental health
conditions in the community [1] and primary healthcare
practice [2], collectively signifying a major public health
burden in terms of economic costs [3,4], quality-adjusted* Correspondence: phillip.tully@adelaide.edu.au
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unless otherwise stated.life years, and disability worldwide [5]. Panic disorder is
characterized by recurrent and unexpected panic attacks;
that is, an abrupt surge of intense fear or discomfort
reaching a peak within minutes, during which at least four
of the symptoms listed in Table 1 are experienced in con-
junction with persistent concern or worry about additional
panic attacks or their consequences, or maladaptive be-
haviors including avoidance [6]. Strictly speaking, psychi-
atric diagnostic nomenclature indicates that a panic
disorder diagnosis cannot be applied when panic symp-
toms are the direct result of a medical condition such as
CHD [6]. Yet many symptoms characteristic of a panicis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 List of possible symptoms experienced during a
panic attack
Number Panic disorder symptom
1 Palpitations, pounding heart, or accelerated heart rate
2 Sweating
3 Trembling or shaking
4 Sensations of shortness of breath or smothering
5 Feelings of choking
6 Chest pain or discomfort
7 Nausea or abdominal distress
8 Feeling dizzy, unsteady, light-headed, or faint
9 Chills or heat sensations
10 Paresthesias (numbness or tingling sensations)
11 Derealization (feelings of unreality) or depersonalization
(being detached from oneself)
12 Fear of losing control or ‘going crazy’
13 Fear of dying
Panic disorder/panic attack symptoms adapted from the Diagnostic and
Statistical Manual of Mental Disorders Fifth Edition [6].
Additional qualifiers:
A. A panic attack is an abrupt surge of intense fear or intense discomfort that
reaches a peak within minutes, and during which time four (or more) of the
above symptoms occur.
B. At least one of the attacks has been followed by 1 month (or more) of one
or both of the following:
1. Persistent concern or worry about additional panic attacks or their
consequences (for example, losing control, having a heart attack,
‘going crazy’).
2. A significant maladaptive change in behavior related to the attacks (for
example, behaviors designed to avoid having panic attacks, such as avoidance
of exercise or unfamiliar situations).
A. The disturbance is not attributable to the physiological effects of a
substance (for example, a drug of abuse, a medication) or another medical
condition (for example, hyperthyroidism, cardiopulmonary disorders).
B. The disturbance is not better explained by another mental disorder (for
example, the panic attacks do not occur only in response to feared social
situations, as in social anxiety disorder; in response to circumscribed phobic
objects or situations, as in specific phobia; in response to obsessions, as in
obsessive-compulsive disorder; in response to reminders of traumatic events,
as in posttraumatic stress disorder; or in response to separation from attachment
figures, as in separation anxiety disorder).
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heart disease (CHD) [7] and cardiomyopathies [8], making
differential diagnosis difficult [9]. For example, chest pain
and dyspnea are panic-like symptoms yet also overlap with
those typical of a myocardial infarction (MI) and angina
pectoris. Given the commonality in clinical presentation
of panic attacks and CHD, it has been speculated that
panic disorder is linked with CHD for more than 50 years
[10]. However, the nexus between panic disorder and CHD
remains tenuous [11,12] and is yet to be clarified by means
of a contemporary systematic review.
Part of the suspicion concerning such etiological links
is that persons with panic disorder persist in emergency
department recidivism [13,14] and outpatient examina-
tions for chest pain [15,16] despite negative diagnostic
results from coronary catheterization, electrocardiogram,or serum markers of myocardial damage [17,18]. These
collective findings contrast to more recent evidence re-
vealing plausible mechanisms of cardiopathogenesis at-
tributable to panic disorder and sympathetic discharge
of panic attacks, including reversible myocardial ischemia
[19,20], diminished heart rate variability (HRV) [21], change
in the QRS complex [22], especially the QT-interval
[23-25], serum low density lipoprotein [26], microvascu-
lar disorders including coronary slow-flow [27] and micro-
vascular angina [15], arterial stiffness [28], and also a
preponderance of behavioral factors such as smoking
[29], alcohol use [30], and overt exercise-avoidance behav-
iors [31]. The inconsistency in collective findings to date,
coupled with the high coronary healthcare utilization by
panic disorder patients [32], indicates that a meta-analysis
is both timely and warranted.
Prior reviews concerning panic disorder and CHD have
typically been narrative [11,33-35] or have performed meta-
analysis on panic disorder prevalence in CHD [9,12,36]
but none have quantified possible etiological links. Most
recently, a meta-analysis of 20 studies reported by Roest
and colleagues [37] suggested that anxiety was associated
with a 26% increased risk of CHD and a 48% increased
risk of CHD mortality. However, this previous review [37]
is confounded by numerous methodological shortcom-
ings, thereby limiting the extent to which conclusions
regarding anxiety disorders and incident CHD can be
drawn. Firstly, the meta-analysis included cohorts com-
prised by persons with CHD at baseline (six studies), mix-
ing etiological and prognostic studies, thereby precluding
an evaluation of etiological links. A second limitation is
the inclusion of studies utilizing self-report to ascertain
CHD outcomes [38], which is notably problematic in anx-
iety disorder patients because of their propensity towards
catastrophic misinterpretation of somatic symptoms [39],
and the aforementioned high utilization of emergency de-
partments [32], thus underscoring the requisite need to
prioritize physician diagnoses when establishing etiological
links [39].
Notwithstanding these methodological dilemmas, fur-
ther limitations of the extant evidence base relate to key
conceptual and measurement issues. Specifically, the prior
etiological review concerning anxiety [37] included only
one study adopting anxiety disorder diagnoses (that is,
generalized anxiety disorder), no studies concerning panic
disorder, and excluded several studies pertaining to anx-
iety disorders among non-institutionalized individuals
[40,41]. Therefore, collectively, the prior findings [37] do
not represent the anxiety disorder subtypes observed in
clinical practice, and especially those necessitating psychi-
atric intervention [42]. Rather, the prior meta-analysis [37]
has pooled together broad anxiety domains measured
by self-report anxiety questionnaires. One drawback
of explicating etiological links in this manner is that
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notypes, as for example uncontrollable worry is character-
istic of generalized anxiety disorder, intrusive obsessions
are characteristic of obsessive-compulsive disorder. By
contrast, other self-report measures purported to measure
anxiety do not characterize anxiety per se but rather tend
to measure personality traits (see [43-45]) or non-specific
negative emotions shared with depression (see [46-48]).
For example, the Hospital Anxiety and Depression Scale
(HADS), used in two cohorts, is widely documented for
the undesired psychometric inability to distinguish anxiety
from depression, raising serious concerns about construct
validity [49]. In light of the epidemiological and clinical im-
plications, it is therefore requisite to examine anxiety at
the specific disorder and phenotype level rather than as a
single heterogeneous group, thus allowing for the consider-
able taxonomic, phenotypic, and genetic heterogeneity to
be accounted for [9].
A final limitation of the extant evidence basis concern-
ing anxiety is that the conjoint effects of anxiety and de-
pression with respect to incident CHD is unknown.
Concurrent and lifetime comorbidity between anxiety
and depression is common [50], and some studies have
reported that comorbid anxiety and depression disorder
is associated with a higher CHD risk than either disorder
in isolation [51]; however, such studies have not been
subjected to systematic review and meta-analysis. Collect-
ively, the inconsistencies in prior findings highlight a crit-
ical limitation with respect to clinical diagnosis of panic
disorder and etiology with CHD. A systematic review of
this type, as described herein in a protocol stage, might in
turn assist in the design of subsequent epidemiological
studies and inform clinicians. Herein, we outline a system-
atic review and meta-analysis protocol designed to over-




The proposed review aims to synthesize the evidence
base regarding panic disorder and subsequent CHD. The
reporting of this review will conform to the PRISMA
guidelines [52].
Search strategy
We will identify relevant articles in any language by searching
electronic databases from inception including: MEDLINE,
EMBASE, SCOPUS, and PsycINFO. The search strategy
is provided in Additional file 1. We will perform a hand
search of the reference lists of articles selected to supple-
ment the electronic search. In addition, a hand search will
be performed of prior narrative reviews concerning panic
disorder [11,12,53]. The principal investigators of stud-
ies will also be contacted to ascertain unpublished dataand determine other studies not yielded by our primary
search. The grey literature/unpublished studies will not be
searched on an electronic database.
Eligibility criteria
Population: The population of interest are persons with
panic disorder at baseline but without verified or known
CHD at this time. To be eligible, panic disorder must be
reported according to a recognized clinical criteria, in-
cluding the Diagnostic and Statistical Manual of Mental
Disorders (DSM) or the International Classification of
Diseases, or determined by a standardized interview (for ex-
ample, Structured Clinical Interview, Composite International
Diagnostic Interview), or diagnosis made by a qualified
professional (for example, psychiatrist, psychologist, gen-
eral physician), or medical records. Studies reporting panic
disorder ± agoraphobia/phobic neurosis, panic disorder ±
other anxiety disorder, or a validated self-report measure
of panic attack or panic attack symptoms, or anxiety neur-
osis, the diagnostic precursor to panic disorder in ICD, are
eligible. In the case that studies adopt a measure of gen-
eral anxiety, we specify that at least 85% of items have to
be deemed by blind reviewers as symptomatic of PD to be
included in the analyses. Single-item measures are eligible
only if they explicitly refer to a panic attack or panicky
sensation. Studies are eligible if reporting from the gen-
eral, cardiology, or psychiatric population (in- and outpa-
tients). Studies must be performed among young adults
(≥15 years) or adult populations (no upper limit of age for
inclusion).
Comparator/control: Participants without verified or
known CHD, and without panic disorder, at baseline from
the general, cardiology, or psychiatric population (in- and
outpatients).
Outcomes: Incident CHD will be considered as follows:
1. Major adverse cardiac events - defined as documented
death due to CHD, cardiac arrest (including ventricular
fibrillation), sudden cardiac death or myocardial
infarction (fatal or non-fatal).
2. Structural coronary artery disease - as evidenced by
obstructive coronary artery disease (≥50% stenosis)
on coronary angiography and/or subsequent coronary
revascularization.
3. Ischemic heart disease - clinical evidence of myocardial
ischemia on ECG (transient ST/T wave changes),
myocardial scintigraphy (reversible defect),
echocardiography (transient wall motion abnormality),
or cardiac magnetic resonance imaging (perfusion
defect or transient wall motion abnormality),
either during a spontaneous episode or a provocative
stress stimulus.
4. Other CHD - physician or cardiologist diagnosed
CHD.
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CHD (CHD endpoint levels 1 to 4), fatal CHD (verified
death for CHD, levels 1 to 4), and fatal or non-fatal MACE
(CHD level 1).
Study design: Only peer reviewed studies in full-text,
conference abstract, or doctoral dissertations are eligible
for this review if published in English. Observational stud-
ies designed as longitudinal cohort, case–control study, or
database registry and experimental studies designed as
randomized controlled trials or non-randomized trials will
be eligible for this review. Prospective and retrospective
studies will be eligible. We will exclude cross-sectional
studies, case series, and case reports.
Exclusion: Studies utilizing only patient self-report to
determine incident CHD, including self-report of a phys-
ician diagnosis. Studies reporting neurocirculatory asthenia,
cardiac neurosis, effort syndrome, or Da Costa’s syndrome
are ineligible as they precede panic disorder [10] or are
re-conceptualized under multiple psychosomatic disor-
ders [54].Study selection process
Initially, two reviewers (PJT, SC) will independently screen
titles and abstracts of all the retrieved bibliographic re-
cords. Full texts of all potentially eligible records passing
the title and abstract screening level will be retrieved and
examined independently by the two reviewers according
to the abovementioned eligibility criteria. Disagreements
at both screening levels (title/abstract and full text) will
be adjudicated by discussion with a third reviewer (HB).
A PRISMA flow chart will outline the study selection
process and reasons for exclusions.Data items for collection
After determination of the initial study, eligibility infor-
mation will be extracted for each study pertaining to
study identification (first author, year of publication,
country where recruitment took place), study design
characteristics (sample size, duration of follow-up), pa-
tient population (age, gender, proportion with comorbid
hypertension, hypercholesterolemia and diabetes), the
type of CHD endpoint (type of CHD, criteria for CHD),
and adjustment for covariates (complete list of variables).
Primary outcome data collected will include CHD, re-
ported either as categorical numbers (numerator and de-
nominator) or the statistical effect size (that is, risk ratio,
hazard ratio, incidence rate ratio, odds ratio) and the 95%
confidence interval (CI). These variables will be extracted
for all studies by one reviewer (PJT), after which the ex-
tracted data will be verified by a second reviewer (SC) to
reduce reviewer errors and bias. All disagreements will be
handled by consensus between the three reviewers (PJT,
SC, HB).Risk of bias
The RTI item bank will be utilized to identify methodo-
logical bias among the identified studies [55]. The RTI
item bank consists of 29 items for evaluating the risk of
bias in observational studies, interventions, or exposures.
The RTI was developed from an initial pool of 1,492 items
based on face validity, cognitive, content validity, and
inter-rater reliability testing.
The scale has demonstrated inter-rater reliability. Risk
of bias will be independently undertaken by two reviewers
(PJT, SC) and disagreements adjudicated by consensus
with a third reviewer (HB). The RTI item bank is provided
in Additional file 2.Synthesis of data and summary measures
Data synthesis
We will provide a detailed description of the results in
both tables and text for all included studies. We will
qualitatively describe the studies pertaining to study
identification (first author, year of publication, country
where recruitment took place), study design and charac-
teristics (observational or experimental, sample size, dur-
ation of follow-up), patient population (age, gender), the
classification of panic disorder or symptoms (description
of clinical interview or panic questionnaire), the type
of CHD endpoint (type of CHD, criteria for CHD), the
length of follow-up, and adjustment for covariates (list of
variables).Meta-analysis
We will use RevMan 5.3 to conduct the meta-analyses.
The summary effect measures may include hazard ratios,
relative risk, or odds ratios. When data are available to
be pooled together, we will use a random-effects model
using the inverse variance method which provides a
more conservative estimate of effect size. Where possible
we will aggregate each included study’s CHD outcome
data as hazard ratios, relative risk, or odds ratios with
the associated 95% CIs as these are presumed to meas-
ure the same underlying effect [56] and consensus that
these are approximately equivalent for effect sizes less
than 2.5 and follow-up less than 20 years [57]. In studies
where an effect size is not reported, we will extract the
individual cell data and calculate the RR and 95% CI. In
the first instance, we will pool together the unadjusted
effect sizes for each CHD outcome (permitting age and
sex adjustment). In the second instance, we will pool to-
gether the unadjusted and most adjusted effect sizes for
each CHD outcome. Heterogeneity will be evaluated
with the I2 statistic. According to the Cochrane Hand-
book for Systematic Reviews [58], I2 of 0% to 60% can
be regarded as not important to moderate, while I2 >
60% indicates substantial heterogeneity.
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There is a likelihood of more than one reported eligible
endpoint per study [59], we will include data as follows:
1. the CHD endpoint with the largest N will be priori-
tized, then fatal and non-fatal MACE, then obstructive
coronary artery disease, ischemic heart disease, and clin-
ician diagnosed CHD; 2. in the case where several CHD
outcome measures of the same hierarchy level are used in
one study, we will select the outcome measure that is used
most frequently across the eligible studies, if possible.
Planned subgroup analyses
Subgroup analyses will be performed for the primary CHD
endpoint on psychiatric classification level (1) studies util-
izing anxiety neurosis diagnoses versus all other anxiety
classifications; (2) studies utilizing self-report symptoms
versus all others; (3) studies utilizing panic disorder versus
all others; (4) psychiatric inpatients [60] versus outpatients
or community samples; (5) persons with panic comorbid
with a depression disorder versus persons with panic only;
(6) effect sizes adjusted for depression versus studies not
adjusted for depression [61]; and (7) known psychosocial
correlates and CHD risk factors [62] including effect sizes
adjusted for alcohol; (8) adjusted for tobacco smoking; (9)
adjusted for socioeconomic status.
We will also perform subgroup analysis stratified by
groups of patients who undergo coronary catheterization
with negative results at baseline versus all other groups
of patients with indeterminate baseline CHD. We will
also perform subgroup analyses stratified by gender if
possible. In the event that stratified gender analyses is
not possible, we will utilize meta-regression to perform
analyses adjusted for the percentage of males/females in
the total sample based on the preponderance to PD in
females and preponderance to CHD in males, and age
(mean or median). Sensitivity analyses will evaluate the
effects of age <50 and >50 years, or alternatively as mean
or median age in meta-regression. This is based on the a
priori higher probability for older persons to have CHD,
CAD, myocardial infarction, cardiomyopathy, and atrial
fibrillation.
Planned sensitivity analyses
Because of possible under- or overestimation of effect
sizes, we will adopt Loef and Walach’s [56] methodology
for sensitivity analyses and apply the natural logarithms of
calculated values and calculate the standard errors based
on 95% CIs.
Sensitivity analyses will be performed for the primary
CHD endpoint, and we will assess general study-level
characteristics as potential sources of heterogeneity (1)
studies adjusting for reverse causation bias by excluding
CHD events occurring in the first 2 years of follow-up; (2)
retrospective studies; (3) region or country of recruitment;(4) unpublished studies; (5) length of follow-up. Due to
the nature of CHD outcomes assessed in the review, it is
possible that studies will report multiple observations with
heterogeneity concerning the length of follow-up. We will
analyze follow-up duration using different time frames: 1.
short term (up to 2 years); 2. medium term (2 to 10 years);
and 3. long term (more than 10 years). Our inclusion cri-
teria do not specify requisite time points at which out-
comes are measured to avoid excluding potentially useful
information; however, we will account for timing during
data analysis. We intend to group all studies together ini-
tially and then perform sensitivity analyses for different
time points (for example, CHD in the short, medium, and
long terms), if possible.
Assessment of publication bias
The test of Egger et al. [63] and the funnel plot will be
used to evaluate the presence of publication bias.
GRADE framework for quality of evidence
The proposed review will use the Grading of Recom-
mendations Assessment, Development and Evaluation
(GRADE) guidelines [64] to determine the quality of evi-
dence and the strength of recommendations. The GRADE
guidelines will be applied separately to each of the CHD
endpoints, providing a summary of findings table with
qualitative description as either high, moderate, low,
or very low.
Discussion
This systematic review aims to add to the extant litera-
ture by aggregating data concerning the risk of incident
CHD attributable to panic disorder in persons originally
free from CHD. Our review will extend beyond previous
systematic reviews including those concerning post-
traumatic stress disorder [65] and, indeed, a prior review
concerning anxiety symptoms [37]. Furthermore, the find-
ings will potentially need to be considered alongside a
plethora of psychosocial risk factors also purported to in-
crease CHD risk, and these include depression [66-68],
stress [69], anger and hostility [70], and Type A personal-
ity [71] to ensure uniqueness of the findings from related
negative emotions [72]. The findings might therefore serve
to clarify the design of future epidemiological and clinical
studies and also potentially inform evidence-based clinical
practice and policy concerning triaging chest pain patients
[17], diagnostic assessment [8], and psychiatric interven-
tion with panic disorder patients [73].
There are several limitations that will contextualize
the findings and generalizability of the proposed review
including the interrelatedness of psychiatric disorders espe-
cially anxiety and depression disorders [74,75]. Moreover,
studies will potentially determine panic disorder status
by different means such as clinical interview, physician
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Therefore, the proposed review may be limited by the
pooling together of panic disorder studies with varying
levels of validity and heterogeneity. A related limitation
concerns the CHD endpoints, and it is possible that differ-
ent studies will utilize varying methods to determine CHD
status at follow-up, each with varying levels of validity and
conclusiveness. This limitation is important in our pro-
posed review’s context since that we are largely assessing
etiological links assuming that panic precedes CHD, when
it is plausible that panic is merely a manifestation of un-
diagnosed cardiovascular dysfunction, coronary spasm, or
sub-clinical CHD. Indeed, panic disorder diagnoses are
sometimes applied mutually exclusively to CHD once ex-
ploratory diagnostic tests for myocardial infarction are
negative [17]. Limitations of the original studies may also
include between study heterogeneity and high risk of bias
that will potentially limit the conclusions drawn. Specific-
ally, it is possible that retrospective studies will be charac-
terized by a high risk of bias. Finally, despite attempts to
retrieve unpublished and nonsignificant studies, the pro-
posed systematic review is likely to be limited by publica-
tion bias of only significant findings, given the infancy of
the literature [76]. Moreover, as the proposed review will
include only English language studies, the generalizability
of the findings to studies published in other languages and
other healthcare settings is limited.
In conclusion, given that panic disorder and incident
CHD links are tenuous and the absence of a contempor-
ary meta-analysis on this topic, the proposed review will
help in summarizing the available evidence. The findings
may have implications for clinical practice and policy.Additional files
Additional file 1: Table showing the search strings for MEDLINE,
EMBASE, PsychINFO and SCOPUS. This table shows the search string
for the systematic review for each of the databases utilized in our review,
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Additional file 2: RTI Risk of bias item bank. This table shows each of
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